Neurocrine Biosciences shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $40M | 281k | 140.38 |
| 2025-06-30 | $31M | 249k | 125.69 |
| 2025-03-31 | $6.2M | 56k | 110.60 |
| 2024-12-31 | $8.7M | 64k | 136.50 |
| 2024-09-30 | $2.0M | 17k | 115.22 |
| 2024-06-30 | $307k | 2.2k | 137.67 |
| 2023-12-31 | $3.7M | 28k | 131.76 |
| 2023-09-30 | $7.9M | 70k | 112.50 |
| 2023-06-30 | $15M | 162k | 94.30 |
| 2023-03-31 | $24M | 241k | 101.22 |
| 2022-12-31 | $21M | 177k | 119.44 |
| 2022-09-30 | $21M | 197k | 106.21 |
| 2022-06-30 | $21M | 215k | 97.48 |
| 2022-03-31 | $20M | 210k | 93.75 |
| 2021-12-31 | $4.4M | 52k | 85.17 |
| 2021-03-31 | $446k | 4.6k | 97.25 |
| 2020-09-30 | $1.0M | 11k | 96.20 |
| 2018-09-30 | $366k | 3.0k | 123.03 |
| 2015-03-31 | $1.4M | 36k | 39.72 |
| 2014-12-31 | $1.0M | 46k | 22.33 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management